Biomarkers for Oncology
JH · Effective Oct 1, 2015
9 active Medicare policies list N42.39, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JL · Effective Apr 24, 2025
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of N42.39 |
|---|---|---|
| Prostate Biopsy | Sep 26, 2023 | Covered |
| Prostate Cancer Screening | Jul 14, 2023 | Covered |
| Policy | Effective | Status of N42.39 |
|---|---|---|
| Prostate Specific Antigen Testing | Apr 15, 2026 | Covered |